• 22747 Citations
  • 59 h-Index
1979 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Personal profile

Research Biography

Professor Aylward graduated from Medicine at Oxford University and completed post graduate training in Cardiology in the U.K. and at Flinders Medical Centre, Adelaide. He completed a PhD in Cardiovascular physiology at Flinders University. He did a clinical and research fellowship at the University of Iowa Hospital and Clinics, United States. He became a Staff Specialist in the Division of Medicine at Flinders Medical Centre in 1986.

He has been involved in large scale multinational clinical trials since 1988. He has been the Australian lead investigator and member of a number of international executive steering committees. He has overseen clinical trial organisations at Flinders Medical Centre and SAHMRI which have managed clinical trials in Australia. 

 

Research Expertise

Expertise in large scale clinical trials and their design, management and interpretation.

Research Interests

Clinical trials in Cardiology particularly acute coronary syndromes, lipid management and heart failure.

Education/Academic qualification

Postgraduate Certificate, Cardiac Society of Australia and New Zealand

Award Date: 31 Dec 2005

Postgraduate Certificate, American College of Cardiology

Award Date: 31 Dec 2004

Postgraduate Certificate, Royal College of Physicians, London

Award Date: 31 Dec 1995

PhD, Flinders University

Award Date: 31 Dec 1984

Postgraduate Certificate, Royal Australasian College of Physicians

Award Date: 31 Dec 1981

Master of Arts, University of Oxford

Award Date: 31 Dec 1974

Bachelor, University of Oxford

Award Date: 31 Dec 1974

External positions

Director E2P (Evidence to Practice), South Australian Health and Medical Research Institute

1 Jan 2018 → …

Life Long Health, South Australian Health and Medical Research Institute

1 Jan 2012 → …

Keywords

  • R Medicine (General)
  • Clinical Trials
  • Cardiology

Fingerprint Dive into the research topics where Philip Aylward is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 5 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Caffeinated Beverage Intake, Dyspnea With Ticagrelor, and Cardiovascular Outcomes: Insights From the PEGASUS-TIMI 54 Trial

Furtado, R. H. M., Venkateswaran, R. V., Nicolau, J. C., Gurmu, Y., Bhatt, D. L., Storey, R. F., Steg, P. G., Magnani, G., Goto, S., Dellborg, M., Kamensky, G., Isaza, D., Aylward, P., Johanson, P. & Bonaca, M. P., 18 May 2020, In : Journal of the American Heart Association. 9, 10, p. e015785 25 p.

Research output: Contribution to journalArticle

Open Access
File
  • Effect of Alirocumab on Lipoprotein(a) and Cardiovascular Risk After Acute Coronary Syndrome

    ODYSSEY OUTCOMES Committees and Investigators, Bittner, V. A., Szarek, M., Aylward, P. E., Bhatt, D. L., Diaz, R., Edelberg, J. M., Fras, Z., Goodman, S. G., Halvorsen, S., Hanotin, C., Harrington, R. A., Jukema, J. W., Loizeau, V., Moriarty, P. M., Moryusef, A., Pordy, R., Roe, M. T., Sinnaeve, P., Tsimikas, S. & 6 others, Vogel, R., White, H. D., Zahger, D., Zeiher, A. M., Steg, P. G. & Schwartz, G. G., 21 Jan 2020, In : Journal of The American College of Cardiology. 75, 2, p. 133-144 12 p.

    Research output: Contribution to journalArticle

    Open Access
    File
  • 22 Citations (Scopus)

    Dapagliflozin and cardiovascular outcomes in type 2 diabetes

    Wiviott, S. D., Raz, I., Bonaca, M. P., Mosenzon, O., Kato, E. T., Cahn, A., Silverman, M. G., Zelniker, T. A., Kuder, J. F., Murphy, S. A., Bhatt, D. L., Leiter, L. A., McGuire, D. K., Wilding, J. P. H., Ruff, C. T., Gause-Nilsson, I. A. M., Fredriksson, M., Johansson, P. A., Langkilde, A. M., Sabatine, M. S. & 8 others, DECLARE–TIMI 58 Investigators, Aylward, P., Lewis, B., Stranks, S., Lehman, R., Hamilton, A., Shah, R. & Wood, J., 24 Jan 2019, In : New England Journal of Medicine. 380, 4, p. 347-357 11 p.

    Research output: Contribution to journalArticle

  • 1090 Citations (Scopus)

    Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial

    Ray, K. K., Colhoun, H. M., Szarek, M., Baccara-Dinet, M., Bhatt, D. L., Bittner, V. A., Budaj, A., Diaz, R., Goodman, S. G., Hanotin, C., Harrington, R. A., Jukema, J. W., Loizeau, V., Lopes, R. D., Moryusef, A., Murin, J., Pordy, R., Ristic, A. D., Roe, M. T., Tuñón, J. & 18 others, White, H. D., Zeiher, A. M., Schwartz, G. G., Steg, P. G., ODYSSEY OUTCOMES Committees and Investigators, Aylward, P. E., Kim, S-H., Vogel, R., Roberts-Thomson, P., Lehman, S. J., Robinson, S., Davies, R., Wang, J., Feng, Y., Alan, D., Nielsen, P. K., Smith, S. & Henderson, D., 1 Jul 2019, In : The Lancet Diabetes and Endocrinology. 7, 8, p. 618-628 11 p.

    Research output: Contribution to journalArticle

  • 53 Citations (Scopus)

    Effects of Alirocumab on Cardiovascular Events After Coronary Bypass Surgery

    Aylward, P. E. & ODYSSEY OUTCOMES Committees and Investigators, 3 Sep 2019, In : Journal of The American College of Cardiology. 74, 9, p. 1177-1186 10 p.

    Research output: Contribution to journalArticle

  • 8 Citations (Scopus)